申请人:ASTRAZENECA UK LTD
公开号:WO2000027842A1
公开(公告)日:2000-05-18
There are provided novel compounds of formula (I) wherein R?1, R2, R3, R4, R5¿, A, Q, X, Y, and Z are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and tautomers thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain.
提供了式(I)的新化合物,其中R?1,R2,R3,R4,R5¿,A,Q,X,Y和Z如规范所定义,以及其药学上可接受的盐,对映异构体和互变异构体;以及它们的制备方法,含有它们的组合物以及它们在治疗中的用途。这些化合物是一氧化氮合酶的抑制剂,因此在治疗或预防炎症性疾病和疼痛方面特别有用。